Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 235 articles:
HTML format



Single Articles


    June 2022
  1. ANDERSON CM, Lee CM, Saunders D, Curtis AE, et al
    Two-Year Tumor Outcomes of Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiation Therapy and Ciplatin for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 17. pii: S0360-3016(22)00608.
    PubMed     Abstract available


  2. TAYLOR CL, Price JM
    The Tooth Hurts: Dental Health After Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:331-334.
    PubMed    


  3. MCDOWELL L, Chua MLK, Beadle BM, Ma DJ, et al
    A Bit More Here and a Little Less There: The Trials (and Tribulations) of Adjuvant and Neoadjuvant Head and Neck Studies in 2021.
    Int J Radiat Oncol Biol Phys. 2022;113:243-251.
    PubMed    


  4. CARDENAS CE, Blinde SE, Mohamed ASR, Ng SP, et al
    Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study.
    Int J Radiat Oncol Biol Phys. 2022;113:426-436.
    PubMed     Abstract available


  5. SCHRODER C, Kothe A, De Angelis C, Basler L, et al
    NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors.
    Int J Radiat Oncol Biol Phys. 2022;113:448-455.
    PubMed     Abstract available


    May 2022
  6. LIU X, Guo L, Xie FY, Hu WH, et al
    Necrosis in a Biomarker-driven, Phase 2 Trial of Adjuvant Apatinib in Patients of Nasopharyngeal Carcinoma with Residual Epstein-Barr Virus DNA after Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 May 9. pii: S0360-3016(22)00410.
    PubMed     Abstract available


  7. BUCKSTEIN MH, Anker CJ, Chuong MD, Hawkins MA, et al
    CROSSing into New Therapies for Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:5-10.
    PubMed    


  8. NG SP, Corry J, Ng WT
    The Janus Face in Defining the Optimal Radiation Dose for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;113:114-116.
    PubMed    


  9. PAKKANEN P, Irjala H, Ilmarinen T, Halme E, et al
    Survival and Larynx Preservation in Early Glottic Cancer: A Randomized Trial Comparing Laser Surgery and Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;113:96-100.
    PubMed     Abstract available


    April 2022
  10. WARD MC, Koyfman SA, Bakst RL, Margalit DN, et al
    Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society(R) (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Apr 7. pii: S0360-3016(22)00280.
    PubMed     Abstract available


  11. LU DJ, Luu M, Gay C, Nguyen AT, et al
    Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931.
    Int J Radiat Oncol Biol Phys. 2022 Apr 5. pii: S0360-3016(22)00279.
    PubMed     Abstract available


  12. LIAO W, He J, Luo X, Wu M, et al
    Automatic delineation of gross tumor volume based on magnetic resonance imaging by performing a novel semi-supervised learning framework in nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Apr 2. pii: S0360-3016(22)00277.
    PubMed     Abstract available


  13. HE L, Pi Y, Li Y, Wu Y, et al
    Efficacy and safety of apatinib in radiation-induced brain injury among head and neck cancer: an open-label, single-arm, phase 2 study.
    Int J Radiat Oncol Biol Phys. 2022 Apr 1. pii: S0360-3016(22)00268.
    PubMed     Abstract available


  14. QIU Y, Hu W, Wen M, Zhao W, et al
    Low Expression of ECT2 Confers Radiation Therapy Resistance Through Transcription Coupled Nucleolar DNA Damage Repair.
    Int J Radiat Oncol Biol Phys. 2022;112:1229-1242.
    PubMed     Abstract available


    March 2022
  15. MCDOWELL L, Bossi P
    The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?
    Int J Radiat Oncol Biol Phys. 2022;112:938-941.
    PubMed    


  16. HU K, Persky M
    Depth of Invasion in Oral Tongue Cancer and Risk of Regional Failure.
    Int J Radiat Oncol Biol Phys. 2022;112:851-852.
    PubMed    


  17. KILIC SS, Campbell SR
    Don't Take the Bait, Radiate: Importance of Adjuvant Radiation Therapy for Oral Tongue Cancer.
    Int J Radiat Oncol Biol Phys. 2022;112:850.
    PubMed    


  18. HARA JHL, Juloori A
    Node Out, About It? Consideration of Adjuvant Treatment of Oral Tongue Cancer.
    Int J Radiat Oncol Biol Phys. 2022;112:849.
    PubMed    


  19. COOK A, Modh A, Ali H, Sheqwara J, et al
    Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;112:926-937.
    PubMed     Abstract available


  20. NI R, Zhou T, Ren G, Zhang Y, et al
    Deep learning-based automatic assessment of radiation dermatitis in nasopharyngeal carcinoma (NPC) patients.
    Int J Radiat Oncol Biol Phys. 2022 Mar 15. pii: S0360-3016(22)00244.
    PubMed     Abstract available


  21. LI Y, Sakai M, Tsunoda A, Kubo N, et al
    Normal Tissue Complication Probability Model for Acute Radiation Dermatitis in Patients with Head and Neck Cancer Treated with Carbon Ion Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 Mar 9. pii: S0360-3016(22)00195.
    PubMed     Abstract available


  22. JOHUNG KL, Park HS
    Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control.
    Int J Radiat Oncol Biol Phys. 2022;112:585.
    PubMed    


    January 2022
  23. FU S, Li Y, Han Y, Wang H, et al
    Diffusion-weighted MRI-guided dose painting in patients with locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus concurrent chemoradiotherapy: a randomized, controlled clinical trial.
    Int J Radiat Oncol Biol Phys. 2022 Jan 21. pii: S0360-3016(22)00001.
    PubMed     Abstract available


    December 2021
  24. BRENNAN MT, Treister NS, Sollecito TP, Schmidt BL, et al
    Tooth failure post-radiotherapy in head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2021 Dec 5. pii: S0360-3016(21)03219.
    PubMed     Abstract available


  25. YEOH KW, Yong FY
    Combined Modality Therapy in Extranodal NK/T Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1103-1105.
    PubMed    


  26. THOMAS HR, Yom SS
    Right on the Nose: A Case of Locally Invasive Extranodal Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1101-1102.
    PubMed    


  27. CORRY J, Ng WT, Moore A, Choi HCW, et al
    Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.
    Int J Radiat Oncol Biol Phys. 2021;111:1227-1236.
    PubMed     Abstract available


  28. TOMASIK B, Papis-Ubych A, Stawiski K, Fijuth J, et al
    Serum MicroRNAs as Xerostomia Biomarkers in Patients With Oropharyngeal Cancer Undergoing Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:1237-1249.
    PubMed     Abstract available


    November 2021
  29. RINGASH J
    Have We Tipped the Balance in HPV-Associated Oropharyngeal Cancer?: The Patient-Experience Side of the De-Escalation Balance Scale.
    Int J Radiat Oncol Biol Phys. 2021;111:887-889.
    PubMed    


  30. CASSWELL G, Gough K, Drosdowsky A, Bressel M, et al
    Fear of Cancer Recurrence in Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111:890-899.
    PubMed     Abstract available


  31. LI X, Gao H, Zhu J, Huang Y, et al
    3D Deep Learning Model for the Pretreatment Evaluation of Treatment Response in Esophageal Carcinoma: A Prospective Study (ChiCTR2000039279).
    Int J Radiat Oncol Biol Phys. 2021;111:926-935.
    PubMed     Abstract available


  32. RISCHIN D, King M, Kenny L, Porceddu S, et al
    Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study.
    Int J Radiat Oncol Biol Phys. 2021;111:876-886.
    PubMed     Abstract available


  33. LI W, Xiao H, Li T, Ren G, et al
    Virtual Contrast-enhanced Magnetic Resonance Images Synthesis for Patients with Nasopharyngeal Carcinoma using Multimodality-guided Synergistic Neural Network.
    Int J Radiat Oncol Biol Phys. 2021 Nov 11. pii: S0360-3016(21)03115.
    PubMed     Abstract available


  34. WANG Y, Thomas TV, Duggar WN, Roberts PR, et al
    Automatic Extracapsular Extension Identification in Head and Neck Cancer Using Deep Neural Network with Local-Global Information.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  35. ZHU Z, Ho TY, Jin D, Yan K, et al
    Deep Learning Based Lymph Node Gross Tumor Volume Detection via Distance-Guided Gating Using CT and 18F-FDG PET in Esophageal Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  36. WANG Y, Nie S, Chen J, Wang C, et al
    Nomograms Predicting Response and Survival of Esophageal Squamous Cell Carcinoma Patients Treated With Anti-PD-1 Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  37. WANG J, Wang J, Xiao LL, Wang S, et al
    Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  38. PETERS GW, Wang S, Peters NV, Dhanasopan A, et al
    Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  39. MORSE R, Mouw T, Moreno M, Dipasco P, et al
    Comparison of Postoperative Esophagectomy Outcomes in Esophageal Cancer Patients Receiving Preoperative Radiotherapy at an Academic Medical Center vs. Community Medical Centers.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  40. MIYAZAKI T, Myojin M, Takahashi H, Hosokawa M, et al
    The Role of Endoscopic Resection in Long-Term Results of Chemoradiotherapy for T1bN0M0 Thoracic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  41. POKHREL D, Bernard ME, Lockhart D, Jeremiah J, et al
    HyperArc VMAT SRT for Locally Recurrent Previously-Irradiated Head and Neck Cancers: Plan Quality, Treatment Delivery Accuracy and Efficiency.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  42. LYU B, Yin Y, Shi M, Zhao L, et al
    Long-Term Clinical Outcome and Safety Analysis of Superficial Esophageal Cancer Patients Receiving Definite or Adjuvant/Salvage Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  43. LIU J, Zeng X, Zhou X, Xu Y, et al
    Factors Associated with Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  44. LIN ZY, Cai WJ, Chen YY, Gao BZ, et al
    Survival Prediction of Esophageal Cancer Using 3D Residual Autoencoder and Proportional Hazards Model.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  45. AUTREY CM, Mittauer KE, Alvarez D, Chuong MD, et al
    MR-Guided Radiotherapy (MRgRT) for Laryngeal Cancer With Real-Time Visualization of Intrafraction Larynx Motion.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  46. SZEWCZYK C, Liao Y, Al-Khudari S, Jelinek M, et al
    A Novel Immobilization Method Using 3D Printing for the Treatment of Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  47. WU RY, Gao L, Huang X, Xiao J, et al
    Stereotactic Body Radiation Therapy for the First-Line Comprehensive Treatment of Oligometastatic Nasopharyngeal Carcinoma: A Prospective, Single-Arm, Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  48. HO YC, Lai YC, Lin HY, Lin JB, et al
    The Volume of Low-Dose Thoracic Irradiation Influences Systemic Inflammation-Immunity Status After Chemoradiation in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  49. JAWORSKI E, Sun Y, Schonewolf C, Gharzai LA, et al
    Local Control With Cemiplimab Monotherapy for Unresectable Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  50. YANG GQ, Echevarria M, Caudell JJ
    Stereotactic Body Radiation Therapy (SBRT) With or Without Daily Systemic Therapy for Re-Irradiation of Unresectable, Recurrent, Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  51. CANAVAN JF, Campbell SR, Koyfman S, Woody NM, et al
    Second Primary Head and Neck Malignancies in Patients With Prior Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) Treated With Radiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  52. DOHOPOLSKI M, Wang K, Morgan HE, Chen L, et al
    Predicting Feeding Tube Placement in Head and Neck Cancer Patients Receiving Radiation Therapy With Machine Learning.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  53. IYER A, Steber C, Porosnicu M, Lycan T, et al
    Short-Course Palliative Radiotherapy Combined With Immunotherapy for Recurrent/Advanced/Metastatic Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  54. VEALE C, Boggs H, Liu Y, McDonald AM, et al
    Predictors of Ability to Complete Prescribed Concurrent Cisplatin Chemotherapy Regimen and Effect on Outcomes in Oropharyngeal Head and Neck Cancer Patients Treated With Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  55. KUTUK T, McAllister N, Rzepczynski AE, Young G, et al
    Submandibular Gland Transfer for the Prevention of Radiation Induced Xerostomia in Head and Neck Cancer - Dosimetric Impact With Intensity Modulated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  56. MAXWELL RJL, Poirier K, Montone K, Swisher-McClure SD, et al
    Detection of Plasma Circulating Tumor-Tissue Modified HPV DNA Following Trans-Oral Robotic Surgery (TORS) and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  57. SHER DJ, Avkshtol V, Moon D, Wang J, et al
    Recurrence and Quality-of-Life Following Involved Node Radiotherapy for Head and Neck Squamous Cell Carcinoma: Initial Results From the Phase II INRT-Air Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  58. LU DJ, Luu M, Gay C, Nguyen AT, et al
    Association of Pathologic Nodal Metastasis Count With Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of RTOG 9501, RTOG 0234, and EORTC 22931.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  59. SAHA S, Mallick I, Chatterjee S
    Adjuvant Radiation Therapy Nodal Target Volumes in Oral Cancer: Do Consensus Guidelines Reflect Patterns of Failure?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  60. LOESER A, Abel J, Kutz LM, Krause L, et al
    Head and Neck Cancer Patients Under (Chemo-) Radiotherapy Undergoing NUTritional Intervention: Results From the Prospective Randomized HEADNUT-Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  61. LOKESH V, Ashalatha D, Naveen T, Vijay C, et al
    Effect of Bio Adhesive Barrier-Forming Oral Liquid on Oral Mucositis Severity and Duration in a Clinical Setting With Concurrent Chemo-Radiation for Patients With Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  62. GEORGE J, Vaughn J, Hobson M, Mittauer KE, et al
    ITV-Negation and Dose Fall-Off Features Result in OAR Dosimetric Superiority Favoring MR-Guided Radiotherapy (MRgRT), and Intensity Modulated Proton Therapy (IMPT) Over Volumetric Modulated Arc Therapy (VMAT) for Treatment of Distal Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  63. ZIYAN Z, Shen M, Jixi L, Kang L, et al
    Genome-Scale CRISPR-Cas9 Knockout Screening in Nasopharyngeal Carcinoma for Radiosensitive and Radioresistant Genes.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  64. YANG Y, Patel SH, Bridhikitti J, Wong WW, et al
    Seed Spots Analysis to Characterize Linear Energy Transfer (LET) Effect in the Adverse Event Regions of Head and Neck Cancer Patients Treated by Intensity Modulated Proton Therapy (IMPT).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  65. ZHOU F, Wang J, Shayan G, Huang X, et al
    Prognostic Significance of Tumor Infiltrating Lymphocytes (TILs) and Programmed Cell Death-Ligand 1 (PD-L1) in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  66. LIU X, Wu B, Huang J, Ding Q, et al
    Patterns of Local-Regional Relapse Following Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  67. PENG X, Liu H, Yin Q, Lang J, et al
    Predictive Value of Ki-67 for Neoadjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  68. LU Y, Huang H
    Maintenance Intervention Improves Survival in Patients With Metastatic Nasopharyngeal Carcinoma Who Benefit From First-Line Treatment: A Prospective Multicenter Randomized Controlled Clinical Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  69. MILLER JA, Huang C, Sahoo MK, Wang H, et al
    Comparison of Multiplex Real-Time PCR and Droplet Digital PCR for Detection of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  70. MILLER JA, Sahoo MK, Huang C, Wang H, et al
    Multiplex Epstein-Barr Virus Genotyping PCR Detects High-Risk Variants in Plasma for Population-Level Nasopharyngeal Carcinoma Screening.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  71. LI Y, Liu Q, Zhu Y, Zang J, et al
    Induction Chemotherapy Followed by Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy in T4N0-1M0 Patients With Nasopharyngeal Carcinoma: A Multicenter Retrospective Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  72. SU H, Jin F, Li Y, Wu W, et al
    Comparative Analysis of Clinical Results of Compared With TPF Induction of Chemotherapy and PF Adjuvant Chemotherapy Combined With Cisplatin Radiochemotherapy for Locally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  73. JACINTO JKM, Huang SH, Su J, Kim J, et al
    Clinical Behavior and Outcome of HPV-Positive Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  74. XU H, Lu L, Lu T, Xu Y, et al
    Identifying the Optimal Candidates for the Best Utilization of Locoregional Radiation Therapy in Patients With De Novo Metastatic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  75. GUO Q, Xiao N, Xu H, Zong J, et al
    Evaluating the Rationality of the International Guideline's Recommendations Regarding Selective Coverage of Level Ib in Node Clinical Target Volume With Nasopharyngeal Carcinoma: Results From a Real-World Series.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  76. FENG M, Yin Q, Qi YX, Lu L, et al
    Low-Dose Ultra-Fractionated Radiotherapy as a Chemosensitizer of Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Preliminary Results of the Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  77. CHOW JCH, Kitpanit S, Lee A, Bao K, et al
    Cranial Neuropathies in Advanced Nasopharyngeal Carcinoma: Neurological Recovery and Prognosis After Modern Radiotherapy and Systemic Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  78. CHUA MLK, Sim AYL, Ong EHW, Huang L, et al
    An Immune-Based Genomic Classifier (GC) Prognosticates for Survival in Endemic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  79. CHENG WJ, Wan SL, Zhaodong F, Zhou Q, et al
    Automatic Gross Tumor Volume Delineation of Nasopharyngeal Carcinoma in 3D CT Images.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  80. FARRIS JC, Steber C, Chan MD, Cramer CK, et al
    IMRT With Planned Gamma Knife Radiosurgery Boost for Head and Neck Cancer With Extensive Disease in Proximity to Critical Structures.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  81. VALLE L, Chu FI, Erman A, Hernandez J, et al
    Patient-Reported Quality of Life Outcomes After Integrating Exclusive Liquid Meal Replacement in Patients With Head and Neck Cancer Undergoing Chemoradiation: Results From a Phase II Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  82. RUHLE A, Stromberger C, Haehl E, Senger C, et al
    Development and External Validation of a Prognostic Classifier for Elderly Head-and-Neck Cancer Patients Undergoing (Chemo)radiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  83. STEBER C, Russell G, Rush MC, Shenker RF, et al
    Impact of Treatment Timing on Disease Outcomes in Patients Treated With Definitive Concurrent Chemoradiation for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  84. AULAKH SS, Dyer BA, Rao SSD
    Evaluation of Risk Factors for Developing Hypothyroidism Following Radiation Therapy for Head and Neck Cancers.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  85. O'KEEFE R, LaRiviere MJ, Vachani C, Hampshire MK, et al
    Contribution of Family History of Head and Neck Cancer and Associated Risk Factors: Analysis of an Internet Based Risk Assessment Tool.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  86. NG SP, Martin GV, Guha-Thakurta N, Wang H, et al
    Patterns of Failure After IMRT and Proton Re-Irradiation for Patients With Recurrent Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  87. LENZIE A, Hoyle J, Yang ES, Spencer SA, et al
    Pain, Weight Loss, and Quality of Life in a Supportive Care Trial for Patients With Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  88. MORENO AC, Wang XA, Mohamed AS, Wang H, et al
    Patterns of Failure After SBRT Reirradiation for Recurrent Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  89. KUT C, McNutt TR, Lee J, Sheikh K, et al
    Spatial Dose Sparing for Organs-at-Risk (OARs) to Decrease Severe Lymphopenia Risks in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  90. LEE J, Lee JJB, Lee CG Jr
    Outcome of Dental Extraction and Implants in Irradiated Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  91. KRC RF, Singh S, Weir JS
    Photobiomodulation Laser Therapy During Chemoradiation for Head and Neck Cancer: Effect on Mucositis, Weight Loss, and Feeding Tube Dependence.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  92. KIM M, Narinesingh D, Hamm J, Marwaha A, et al
    Radiation Therapy in Elderly Patients With Squamous Cell Carcinoma of the Head and Neck - Insights From Real World Registry DATA (2007-2017).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  93. JAWORSKI E, Sun Y, Vineberg KA, Mierzwa ML, et al
    Dosimetric Analysis for Predicting Secondary Lymphedema After Radiation for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  94. KIM K, Doucette A, Amaniera I, Baumann BC, et al
    Acute Toxicity in Patients Treated With Proton vs. Photon Chemoradiotherapy for Locally Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  95. HUSAIN ZA, Chen H, Biswas T, Dagan R, et al
    Outcomes for Oligometastatic Head and Neck Cancer Undergoing SBRT: Results From an International Multi-Institutional Consortium.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  96. ECHEVARRIA M, Chung C, Kirtane K, Kish JA, et al
    Outcomes of Phase I Trial of Patients With Recurrent Head and Neck Squamous Cell Carcinoma Treated With Re-Irradiation With Stereotactic Body Radiation Therapy and Concurrent Cisplatin.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  97. DHAKAL A, Mladkova N, Blakaj DM
    Divergent Role of Intermediate Filaments in Clinical Outcomes of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  98. DOOLEY S, Tobillo R, de Joya E, Freedman LM, et al
    Destructive-Type TP53 Mutations are Independently Associated With Worse Overall Survival in Patients With HPV-Negative Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  99. SCHLAFSTEIN A, Goyal S, Amini A, Karam SD, et al
    Does Operability Status Influence Outcomes in Patients With T4 Larynx Cancer Undergoing Larynx Preservation?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  100. OTSUKA M, Yasuda K, Minatogawa H, Fujita Y, et al
    A Dosimetric Analysis of Locoregional Failure Using Deformable Image Registration in Hypopharyngeal Cancer After Sequential-Boost Intensity-Modulated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  101. LUO X, Yi J, Wang J, Wu R, et al
    Hypopharyngeal Carcinoma With Synchronous and Metachronous Multiple Malignancies: Clinical Characteristics and Prognosis Analysis of 673 Real World Cases.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  102. GONG H, Zhang T, Li M, Peng S, et al
    Radical Surgery vs. Definitive Concurrent Chemoradiotherapy for Locally Advanced Hypopharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  103. LUO X, Yi J, Wu R, Huang X, et al
    Response-Adapted Strategy Based on Early Response to Radiotherapy Achieves Favorable Survival With Functional Larynx in Resectable, Locally Advanced Hypopharyngeal Cancer: An Analysis of 423 Real-World Cases.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  104. ANDERSON E, Luu M, Lu DJ, Chung EM, et al
    Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers in the Modern Imaging Era.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  105. FRANKART AJ, Sadraei NH, Huth B, Redmond KP, et al
    Concurrent Immunotherapy With Chemoradiation for Definitive Management of Locally Advanced Laryngeal Cancer: A Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  106. SABA NF, Wong S, Stokes WA, Rupji M, et al
    CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  107. SHI Z, Zhu X, Ke S, Qiu H, et al
    Clinical Parameters Predicting Prognosis for Elderly Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  108. MLADKOVA N, Blakaj DM, Raval R
    Patterns of Care for Incarcerated Head and Neck Cancer Patient Receiving Radiation: A Single-Center Retrospective Descriptive Cohort Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  109. CHANG X, Zhang W, Yang J, Yu S, et al
    Recurrence Risk Stratification Based on Competing-Risks Nomograms to Identify Patients With Esophageal Cancer Who May Benefit From Postoperative Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  110. SUMNER W, Ray X, Sutton L, Rebibo D, et al
    Genetic Alterations as Predictors of Radiation-Induced Toxicity in Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  111. WANG L, Cao JZ, Wang X, Li Y, et al
    The Molecular Effects of a PARP-1/-2 Inhibitor on Proton and Photon Radiotherapy in Head and Neck Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  112. ZHAO C, Meng X, Jin F, Li Y, et al
    We Hypothesize That BMAL1 Has a Positive Regulatory Effect on the Radiosensitivity of Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  113. DONG J, Wen B, Wang C, Zhang T, et al
    Application of Hypoxia-Driven Dual-Reporter Model to Explore the Effect of Hypoxia on Radiosensitivity of Human Nasopharyngeal Carcinoma Cells.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  114. ROVEDA J, Murdaugh DL, McConathy JE, Milner D, et al
    Brain Glucose Metabolism is Reduced After Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  115. TOBILLO R, de Joya E, Dooley S, Freedman LM, et al
    Female Sex and Increased Immune Marker mRNA Gene Expression are Associated With Decreased Overall Survival in Patients With HPV-Negative Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  116. WANG Y, Li T, Lv J, Xiao L, et al
    Mechanism of Increased Treg Frequency Induced by Irradiated Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  117. JIN F, Chen Y, Jiang Z, Li Y, et al
    The Correlation Study of Circadian Clock Gene BMAL1 Regulates the Biological Behavior of Human Nasopharyngeal Carcinoma Cell After Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  118. HOYLE J, Lenzie A, Kenzik K, Ward K, et al
    Patient Factors Associated With Loss to Radiation Oncology Specialty Follow-Up Among Head and Neck Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  119. MAYO ZS, Ilori E, Fleming CW, Woody NM, et al
    Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy (H-IMRT) for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  120. COKE A, Gilbert M, Hill S, Siddiqui F, et al
    A Multidisciplinary Approach to the Reactive Placement of Nasogastric Feeding Tubes in Clinic During Treatment for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  121. DING S, Liu H, Wang B, Li Y, et al
    Assessment of Dose Accuracy for MR-Guided Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  122. ZAHID MU, Caudell JJ, Moros EG, Mohamed AS, et al
    In Silico Trial to Estimate Personalized RT Dose in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  123. OLSSON CE, Raunert I, Pauli N, Tuomi L, et al
    Feasibility of Mastication-Structure-Sparing Radiotherapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  124. ABUSAIF A, Moawad A, van Dijk LV, Fuentes D, et al
    Radiomic Correlates of Mandibular Osteoradionecrosis After Radiation Treatment of Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  125. GUPTA H, Deek MP, McNutt TR, Lee J, et al
    Predicting Progression-Free Survival Using Primary and Nodal Radiomic Features in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  126. CHEN Q, Bernard ME, Duan J, Feng X, et al
    A Transfer Learning Approach for Improving OAR Segmentation in the Adaptive Therapy or Retreatment of Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  127. DING M, Cui H, Li B, Zou B, et al
    Integrating Preoperative CT and Clinical Factors for Lymph Node Metastasis Prediction in Esophageal Cancer by Feature-Wise Attentional Graph Neural Network (FAGNN).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  128. MORGAN HE, Wang K, Dohopolski M, Liang X, et al
    Explainable Boosting Machine Model with a Parallel Ensemble Design Predicts Local Failure for Head and Neck Cancer With Clinical, CT, and Delta CBCT Radiomic Features.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  129. PIFER P, Kumar M, Yang L, Xie T, et al
    Focal Adhesion Kinase Drives Resistance to Therapy in HPV-Negative Head and Neck Squamous Cell Carcinoma in a p53-Dependent Manner.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  130. MAYO C, Mierzwa ML, Medlin R, Casper K, et al
    Anticipating Poor Outcomes: A Prognostic Machine Learning Model of Unplanned Visits to the Emergency Department for Patients Undergoing Treatment for Head and Neck Cancer Using Comprehensive Multi-Factor Electronic Health Records.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  131. LIU F, Fu SN, Chen YZ, Yan OY, et al
    A Randomized Controlled Trial of Reirradiation Using Diffusion-Weighted MRI Guided Dose-Painting vs. CT-Based Radiotherapy for Locally Recurrent T3 to T4 Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  132. NICOLAY NH, Ruhle A, Mix M, Wiedenmann N, et al
    Development of a Hypoxia-Immune Prognostic Classifier for Head-and-Neck Cancer Patients Undergoing Radiotherapy - Results From a Prospective Imaging Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  133. MIERZWA ML, Lee C, Schipper M, Aryal MP, et al
    Randomized Phase II Study of DCE-MRI-Based Dose Escalation for Poor-Prognosis Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  134. LEE YS, Bradley ST, Gurel Z, Nickel KP, et al
    Mitophagy Induction by ROS-PINK1 Signaling Protects Head and Neck Cancer From Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  135. POLAN D, Mierzwa ML, Epelman M, Sun Y, et al
    Prioritized Optimization of Total Toxicity Burden for Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  136. CREHANGE G, M'vondo C, Bertaut A, Pereira R, et al
    Exclusive Chemoradiotherapy With or Without Radiation Dose Escalation in Esophageal Cancer: Multicenter Phase 2/3 Randomized Trial CONCORDE (PRODIGE-26).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  137. FENG M, Yan L, Du X, Wang H, et al
    Early Efficacy Prediction of Nasopharyngeal Carcinoma Based on 3D-ADC Acquired During Radiotherapy: A Phase II Prospective Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  138. BRIZEL DM, Mowery YM, Zhen W, Chan J, et al
    A Phase 1-2 Trial of Concurrent Radiation Therapy, Cisplatin and BMX-001 in Locally Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  139. QIAN DC, Ulrich BC, Peng G, Zhao H, et al
    Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-Treatment DNA Methylation in Peripheral Blood.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  140. XIANG L, Wu J
    Five-Year Result After Reduction of the Target Volume of Intensity Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multicenter, Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  141. LIU F, Fu SN, Yan OY, Chen YZ, et al
    A Randomized Controlled Trial of Cognitive Behavior Therapy for Reducing Anxiety and Depressive Symptoms in Patients With Locally Recurrent Nasopharyngeal Carcinoma Receiving Reirradiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  142. CAI G, Yu J, Meng X
    Dosimetric Predictors of Cardiac Events After Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


    October 2021
  143. RABEN D, Raben A
    A Two-Headed Heated Debate.
    Int J Radiat Oncol Biol Phys. 2021;111:310.
    PubMed    


  144. SIT D, Koh WX, Shokoohi A, Raycraft T, et al
    External Beam Radiation Therapy in pT4 Well-Differentiated Thyroid Cancer: A Population-Based Study of 405 Patients.
    Int J Radiat Oncol Biol Phys. 2021;111:468-478.
    PubMed     Abstract available


  145. LI Y, Liu H, Sun C, Yin X, et al
    Comparison of Clinical Efficacy of Neoadjuvant Chemoradiation Therapy Between Lower and Higher Radiation Doses for Carcinoma of the Esophagus and Gastroesophageal Junction: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2021;111:405-416.
    PubMed     Abstract available


    September 2021
  146. STEENBAKKERS RJHM, van Rijn-Dekker MI, Stokman MA, Kierkels RGJ, et al
    Parotid gland stem cell sparing radiotherapy for head and neck cancer patients: a double-blind randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2021 Sep 23. pii: S0360-3016(21)02827.
    PubMed     Abstract available


  147. VISSER S, den Otter LA, Ribeiro CO, Korevaar EW, et al
    Diaphragm Based Position Verification to Improve Daily Target Dose Coverage in Proton and Photon Radiotherapy Treatment of Distal Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Sep 13. pii: S0360-3016(21)02814.
    PubMed     Abstract available


  148. INDELICATO DJ, Dagan R
    A Young Patient with EBV-Positive Nasopharyngeal Carcinoma: Dissonance of Dose, Variance of Volume, and Tussle of Timing.
    Int J Radiat Oncol Biol Phys. 2021;111:9-10.
    PubMed    


  149. WU CC, Krasin MJ
    Management of Pediatric Nasopharyngeal Carcinoma: A Role for RT Dose De-escalation.
    Int J Radiat Oncol Biol Phys. 2021;111:11.
    PubMed    


  150. MIERZWA M, Beadle BM, Chua MLK, Ma DJ, et al
    Something for Everyone From Low-Risk to High-Risk: 5 Recent Studies to Improve Treatment and Surveillance for All Patients With Squamous Cell Carcinoma of the Head and Neck.
    Int J Radiat Oncol Biol Phys. 2021;111:1-8.
    PubMed    


  151. LOIZEAU N, Fabiano S, Papp D, Stutzer K, et al
    Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:196-207.
    PubMed     Abstract available


    August 2021
  152. NAZ S, Leiker AJ, Choudhuri R, Preston O, et al
    Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.
    Int J Radiat Oncol Biol Phys. 2021;110:1295-1305.
    PubMed     Abstract available


  153. BISHOP AJ, Livingston JA, Ning MS, Valdez ID, et al
    Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:1496-1504.
    PubMed     Abstract available


  154. PRASANNA PG, Rawojc K, Guha C, Buchsbaum JC, et al
    Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:1325-1340.
    PubMed     Abstract available


    June 2021
  155. ENGESETH GM, He R, Mirkovic D, Yepes P, et al
    Mixed effect modelling of dose and Linear Energy Transfer correlations with brain image changes after intensity modulated proton therapy for skull base head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jun 18. pii: S0360-3016(21)00734.
    PubMed     Abstract available


  156. ZAHID MU, Mohsin N, Mohamed ASR, Caudell JJ, et al
    Forecasting Individual Patient Response to Radiotherapy in Head and Neck Cancer with a Dynamic Carrying Capacity Model.
    Int J Radiat Oncol Biol Phys. 2021 Jun 5. pii: S0360-3016(21)00676.
    PubMed     Abstract available


  157. YOKOTA T, Zenda S, Ota I, Yamazaki T, et al
    Phase 3 randomized trial of topical steroid versus placebo for prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiation.
    Int J Radiat Oncol Biol Phys. 2021 Jun 5. pii: S0360-3016(21)00677.
    PubMed     Abstract available


  158. THOMPSON LMA, Donovan KA
    Discussions About Sexual Health: An Unmet Need Among Patients With Human Papillomavirus-Related Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:394-395.
    PubMed    


  159. KOTHE A, van Luijk P, Safai S, Kountouri M, et al
    Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy.
    Int J Radiat Oncol Biol Phys. 2021;110:587-595.
    PubMed     Abstract available


  160. TAKEMOTO N, Seo Y, Nakahara S, Yoshioka Y, et al
    Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.
    Int J Radiat Oncol Biol Phys. 2021;110:403-411.
    PubMed     Abstract available


  161. WADDLE MR, Ma DJ, Visscher SL, Borah BJ, et al
    Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.
    Int J Radiat Oncol Biol Phys. 2021;110:396-402.
    PubMed     Abstract available


  162. MIERZWA ML, Gharzai LA, Li P, Wilkie JR, et al
    Early MRI Blood Volume Changes in Constrictor Muscles Correlate With Postradiation Dysphagia.
    Int J Radiat Oncol Biol Phys. 2021;110:566-573.
    PubMed     Abstract available


  163. CASSWELL G, Gough K, Drosdowsky A, Bressel M, et al
    Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional Study.
    Int J Radiat Oncol Biol Phys. 2021;110:382-393.
    PubMed     Abstract available


    May 2021
  164. VANDEN BOSCH L, van der Laan HP, van der Schaaf A, Oosting SF, et al
    Patient-reported toxicity and quality of life profiles in head and neck cancer patients treated with definitive radiotherapy or chemoradiation.
    Int J Radiat Oncol Biol Phys. 2021 May 25. pii: S0360-3016(21)00656.
    PubMed     Abstract available


  165. WANG L, Gao Z, Li C, Sun L, et al
    Computed tomography-based delta-radiomics analysis for discriminating radiation pneumonitis in patients with esophageal cancer after radiation therapy.
    Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00475.
    PubMed     Abstract available


  166. MOLLER DS, Poulsen PR, Hagner A, Dufour M, et al
    Strategies for motion robust proton therapy with pencil beam scanning of esophageal cancer.
    Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00468.
    PubMed     Abstract available


  167. VAN DIJK LV, Abusaif AA, Rigert J, Naser MA, et al
    Normal Tissue Complication Probability (NTCP) prediction model for osteoradionecrosis of the mandible in head and neck cancer patients following radiotherapy: Large-scale observational cohort.
    Int J Radiat Oncol Biol Phys. 2021 May 6. pii: S0360-3016(21)00470.
    PubMed     Abstract available


  168. GRIMM J, Vargo JA, Mavroidis P, Moiseenko V, et al
    Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
    Int J Radiat Oncol Biol Phys. 2021;110:147-159.
    PubMed     Abstract available


    April 2021
  169. XIAO C, Miller AH, Peng G, Levine ME, et al
    Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2021 Apr 18. pii: S0360-3016(21)00362.
    PubMed     Abstract available


  170. FRANKART AJ, Frankart MJ, Cervenka B, Tang AL, et al
    Osteoradionecrosis: Exposing the Evidence Not the Bone.
    Int J Radiat Oncol Biol Phys. 2021;109:1206-1218.
    PubMed     Abstract available


  171. VAN LIMBERGEN EJ, Hoeben A, Lieverse RIY, Houben R, et al
    Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1421-1430.
    PubMed     Abstract available


    March 2021
  172. THOMSON DJ
    Reduced Dose and Volume Elective Nodal Radiation Therapy for Head and Neck Cancer: Challenging the Paradigm.
    Int J Radiat Oncol Biol Phys. 2021;109:941-943.
    PubMed    


  173. LUITJE ME, Israel AK, Cummings MA, Giampoli EJ, et al
    Long-Term Maintenance of Acinar Cells in Human Submandibular Glands After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:1028-1039.
    PubMed     Abstract available


  174. ZHU H, Rivin Del Campo E, Ye J, Simone CB 2nd, et al
    Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results from the ESO-Shanghai 1 Trial.
    Int J Radiat Oncol Biol Phys. 2021 Mar 4. pii: S0360-3016(21)00238.
    PubMed     Abstract available


  175. KARAM SD, Anderson CM, Ma D, Chua MLK, et al
    Immunotherapy in Head and Neck Cancer-Ready for Prime Time or More Research Needed?
    Int J Radiat Oncol Biol Phys. 2021;109:647-650.
    PubMed    


  176. BUSZEK SM, Ludmir EB, Grosshans DR, McAleer MF, et al
    Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2021;109:718-725.
    PubMed     Abstract available


  177. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed     Abstract available


  178. DENG J, Dietrich MS, Niermann KJ, Sinard RJ, et al
    Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.
    Int J Radiat Oncol Biol Phys. 2021;109:747-755.
    PubMed     Abstract available


    February 2021
  179. ZHANG YY, Huo WL, Goldberg SI, Slater JM, et al
    Brain-specific RBE of Protons Based on Long-term Outcome of Patients with Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021 Feb 15. pii: S0360-3016(21)00193.
    PubMed     Abstract available


  180. DE GROOT C, Beukema JC, Langendijk JA, Paul van der Laan H, et al
    Radiation-Induced Myocardial Fibrosis in Long Term Esophageal Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021 Feb 9. pii: S0360-3016(21)00174.
    PubMed     Abstract available


  181. CHEN L, Dohopolski M, Zhou Z, Wang K, et al
    Attention Guided Lymph Node Malignancy Prediction in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Feb 6. pii: S0360-3016(21)00171.
    PubMed     Abstract available


  182. NG WT, Soong YL, Chan Ahn Y, AlHussain H, et al
    International Recommendations on Re-irradiation by Intensity-modulated Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021 Feb 2. pii: S0360-3016(21)00115.
    PubMed     Abstract available


  183. LIU WS, Tsai KW, Kang BH, Yang CC, et al
    Simultaneous Reduction of Volume and Dose in Clinical Target Volume for Nasopharyngeal Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;109:495-504.
    PubMed     Abstract available


    January 2021
  184. MCDOWELL L, Rischin D, Lee AWM
    Locoregional Radiation Therapy for De Novo Metastatic Nasopharyngeal Cancer: One Size Fits All?
    Int J Radiat Oncol Biol Phys. 2021;109:131-133.
    PubMed    


  185. ANKER CJ, Dragovic J, Herman JM, Bianchi NA, et al
    Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines.
    Int J Radiat Oncol Biol Phys. 2021;109:186-200.
    PubMed     Abstract available


    December 2020
  186. MCDONALD BA, Vedam S, Yang J, Wang J, et al
    Initial Feasibility and Clinical Implementation of Daily MR-guided Adaptive Head and Neck Cancer Radiotherapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    Int J Radiat Oncol Biol Phys. 2020 Dec 16. pii: S0360-3016(20)34661.
    PubMed     Abstract available


  187. FANG P, Gunther JR, Pinnix CC, Dong W, et al
    A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Dec 9. pii: S0360-3016(20)34644.
    PubMed     Abstract available


  188. MOHAMED ASR, He R, Ding Y, Wang J, et al
    Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study.
    Int J Radiat Oncol Biol Phys. 2020;108:1319-1328.
    PubMed     Abstract available


    November 2020
  189. DYER BA, Mayadev JS
    Restage and Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:849-850.
    PubMed    


  190. MOWERY YM, Vergalasova I, Rushing CN, Choudhury KR, et al
    Early (18)F-FDG-PET Response During Radiation Therapy for HPV-Related Oropharyngeal Cancer May Predict Disease Recurrence.
    Int J Radiat Oncol Biol Phys. 2020;108:969-976.
    PubMed     Abstract available


  191. CHOU WC, Yeh KY, Chang PH, Lu CH, et al
    In Reply to Chow et al.
    Int J Radiat Oncol Biol Phys. 2020;108:832-834.
    PubMed    


  192. CHOW JCH, Cheung KM, Bao KKH, Leung AKC, et al
    In Regard to Chou et al.
    Int J Radiat Oncol Biol Phys. 2020;108:831-832.
    PubMed    


  193. DHARMARAJAN KV, Mohile SG
    Can Geriatric Assessment Measures Be Used to Determine Cancer Treatment Vulnerability in Nongeriatric Patients?
    Int J Radiat Oncol Biol Phys. 2020;108:612-614.
    PubMed    


  194. PRICE JG, Spiegel DY, Yoo DS, Moravan MJ, et al
    Development and Implementation of an Educational Simulation Workshop in Fiberoptic Laryngoscopy for Radiation Oncology Residents.
    Int J Radiat Oncol Biol Phys. 2020;108:615-619.
    PubMed     Abstract available


    October 2020
  195. SHER DJ, Pham NL, Shah JL, Sen N, et al
    Prospective phase II study of radiotherapy dose and volume de-escalation for elective neck treatment of oropharyngeal and laryngeal cancer.
    Int J Radiat Oncol Biol Phys. 2020 Oct 27. pii: S0360-3016(20)34446.
    PubMed     Abstract available


  196. CARDENAS CE, Beadle BM, Garden AS, Skinner HD, et al
    Generating High-Quality Lymph Node Clinical Target Volumes for Head and Neck Cancer Radiotherapy Using a Fully Automated Deep Learning-Based Approach.
    Int J Radiat Oncol Biol Phys. 2020 Oct 14. pii: S0360-3016(20)34392.
    PubMed     Abstract available


  197. MCDOWELL L, Ng SP, Corry J
    COVID-19-An Opportunity for Optimizing Surveillance Protocols During and Beyond the Pandemic: HPV-Associated Oropharyngeal Cancer as an Example of Response-Based Local Surveillance.
    Int J Radiat Oncol Biol Phys. 2020;108:400-403.
    PubMed    


  198. HARARI PM, Lambert PF
    Life Beyond COVID: Pay Attention to Viruses.
    Int J Radiat Oncol Biol Phys. 2020;108:348-350.
    PubMed    


    September 2020
  199. SANTOS M, Oliveira E Silva LF, Kohler HF, Curioni O, et al
    Health-related quality of life outcomes in head and neck cancer: results from a prospective, real world data study with Brazilian patients treated with IMRT, conformal and conventional radiation techniques.
    Int J Radiat Oncol Biol Phys. 2020 Sep 29. pii: S0360-3016(20)34346.
    PubMed     Abstract available


    August 2020
  200. HUANG T, Debelius J, Ploner A, Xiao X, et al
    Radiotherapy-induced Changes of the Nasopharyngeal Commensal Microbiome in Nasopharyngeal Carcinoma Patients.
    Int J Radiat Oncol Biol Phys. 2020 Aug 28. pii: S0360-3016(20)34201.
    PubMed     Abstract available


  201. LI WZ, Lv SH, Liu GY, Liang H, et al
    Development of a prognostic model to identify the suitable definitive radiotherapy candidates in de novo metastatic nasopharyngeal carcinoma: A real-world study.
    Int J Radiat Oncol Biol Phys. 2020 Aug 24. pii: S0360-3016(20)34140.
    PubMed     Abstract available


  202. MENON A, Prem S S, Kumari DR
    Topical betamethasone valerate as a prophylactic agent to prevent acute radiation dermatitis in head and neck malignancies: a randomised, open-label, phase 3 trial.
    Int J Radiat Oncol Biol Phys. 2020 Aug 24. pii: S0360-3016(20)34135.
    PubMed     Abstract available


  203. TANG Q, Wu L, Xu M, Yan D, et al
    Osalmid, a novel identified RRM2 inhibitor, enhances radiosensitivity of esophageal cancer.
    Int J Radiat Oncol Biol Phys. 2020 Aug 4. pii: S0360-3016(20)33741.
    PubMed     Abstract available


    July 2020
  204. OLIN AB, Hansen AE, Rasmussen JH, Ladefoged CN, et al
    Feasibility of multiparametric PET/MRI as a one-stop-shop for radiotherapy planning of head and neck cancer patients.
    Int J Radiat Oncol Biol Phys. 2020 Jul 16. pii: S0360-3016(20)31422.
    PubMed     Abstract available


  205. MEHANNA H, Gillison M, Lee AWM, von Zeidler SV, et al
    Adapting Head and Neck Cancer Management in the Time of COVID-19.
    Int J Radiat Oncol Biol Phys. 2020;107:628-630.
    PubMed    


  206. THOMSON DJ, Yom SS
    In Reply to Gupta et al.
    Int J Radiat Oncol Biol Phys. 2020;107:854.
    PubMed    


  207. GUPTA T, Agarwal JP, Bentzen SM
    In Regard to Thomson et al.
    Int J Radiat Oncol Biol Phys. 2020;107:853-854.
    PubMed    


  208. TSAI CJ, Lee NY
    To Shy Away From Chemotherapy Is to Compromise.
    Int J Radiat Oncol Biol Phys. 2020;107:616-617.
    PubMed    


  209. GARDEN AS
    Regular Ol' Intensity.
    Int J Radiat Oncol Biol Phys. 2020;107:615.
    PubMed    


  210. HUSAIN ZA, Burtness BA
    High Dose Cisplatin: Still the One?
    Int J Radiat Oncol Biol Phys. 2020;107:615-616.
    PubMed    


  211. SIMON AB, Mell LK
    To Intensify or Not to Intensify? Consideration of Competing Risks in the Management of Locoregionally Advanced p16+ Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2020;107:613-614.
    PubMed    


  212. FOSTER CC, Seiwert TY, MacCracken E, Blair EA, et al
    Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes.
    Int J Radiat Oncol Biol Phys. 2020;107:662-671.
    PubMed     Abstract available



  213. Erratum to: Britton B, Baker AL, Wolfenden L, Wratten C, Bauer J, Beck AK, McCarter K, Harrowfield J, Isenring E, Tang C, Oldmeadow C, and Carter G. Eating As Treatment (EAT): A Stepped-Wedge, Randomized Controlled Trial of a Health Behavior Change In
    Int J Radiat Oncol Biol Phys. 2020;107:606.
    PubMed    


  214. LI R, Jiang W, Dou S, Zhong L, et al
    A Phase 2 Trial of Chemoradiation Therapy Using Weekly Docetaxel for High-Risk Postoperative Oral Squamous Cell Carcinoma Patients.
    Int J Radiat Oncol Biol Phys. 2020;107:462-468.
    PubMed     Abstract available


    June 2020
  215. YANG L, Zhang X, MacKay M, Foox J, et al
    Identification of Radioresponsive Genes in Esophageal Cancer from Longitudinal and Single Cell Exome Sequencing.
    Int J Radiat Oncol Biol Phys. 2020 Jun 16. pii: S0360-3016(20)31256.
    PubMed     Abstract available


    May 2020
  216. LI H, Chen X, Zeng W, Zhou W, et al
    Radiation-enhanced expression of CCL22 in nasopharyngeal carcinoma is associated with CCR4(+) CD8 T cell recruitment.
    Int J Radiat Oncol Biol Phys. 2020 May 16. pii: S0360-3016(20)31125.
    PubMed     Abstract available


  217. LIU Q, Zhu Z, Chen Y, Deng J, et al
    Phase II Study of SBRT for Patients With Oligometastatic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 May 14. pii: S0360-3016(20)31127.
    PubMed     Abstract available


  218. GUPTA T, Agarwal JP, Bentzen SM
    Comment on "Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiotherapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement".
    Int J Radiat Oncol Biol Phys. 2020 May 13. pii: S0360-3016(20)31075.
    PubMed    


  219. YANG GQ, Harrison LB
    A Hard Target Needs a Sharper DaRT.
    Int J Radiat Oncol Biol Phys. 2020;107:152-153.
    PubMed    


    April 2020
  220. GOUW ZAR, Fontaine, Vogel WV, van de Kamer JB, et al
    Single-center prospective trial investigating the feasibility of serial FDG-PET guided adaptive radiotherapy for head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2020 Apr 30. pii: S0360-3016(20)31056.
    PubMed     Abstract available


  221. THOMSON DJ, Palma D, Guckenberger M, Balermpas P, et al
    Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement.
    Int J Radiat Oncol Biol Phys. 2020 Apr 14. pii: S0360-3016(20)31034.
    PubMed     Abstract available


  222. FISHER MM, SenthilKumar G, Hu R, Goldstein S, et al
    Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas.
    Int J Radiat Oncol Biol Phys. 2020 Apr 13. pii: S0360-3016(20)30984.
    PubMed     Abstract available


  223. E LONGTON MD, Lawson G, Bihin B, Mathieu I, et al
    Individualized prophylactic neck irradiation in cN0 head and neck cancer patients based on sentinel lymph node(s) identification: definitive results of a prospective phase I-II study.
    Int J Radiat Oncol Biol Phys. 2020 Apr 12. pii: S0360-3016(20)30949.
    PubMed     Abstract available


  224. PORCEDDU SV, Daniels C, Yom SS, Liu H, et al
    Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the delivery of postoperative radiation therapy in complex cutaneous squamous cell carcinoma of the head and neck (cSCCHN).
    Int J Radiat Oncol Biol Phys. 2020 Apr 11. pii: S0360-3016(20)30952.
    PubMed     Abstract available


  225. MIAO J, Di M, Chen B, Wang L, et al
    A Prospective 10-year Observational Study of Reduction of Radiotherapy Clinical Target Volume and Dose in Early-stage Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 Apr 6. pii: S0360-3016(20)30959.
    PubMed     Abstract available


  226. MITCHELL DL, Clinton SK, Old MO
    Not So Fast: Deintensification Therapy for Locally Advanced Oral Cavity Cancer.
    Int J Radiat Oncol Biol Phys. 2020;106:926-927.
    PubMed    


  227. WITEK ME, Harari PM
    Emphasize Treatment of Known Disease Rather Than Past Footprints.
    Int J Radiat Oncol Biol Phys. 2020;106:904.
    PubMed    


  228. CHAN JW
    Salvage Strategies for Neck Recurrences Are Individualized.
    Int J Radiat Oncol Biol Phys. 2020;106:903-904.
    PubMed    


  229. ZUMSTEG ZS
    Balancing Risks and Benefits: Treat Bilateral Necks, But Omit the Tongue.
    Int J Radiat Oncol Biol Phys. 2020;106:902.
    PubMed    


  230. ECHEVARRIA M, Caudell J
    Balancing Risks and Benefits of Dose and Volume of Radiation Therapy in a Neck Recurrence From Tongue Cancer.
    Int J Radiat Oncol Biol Phys. 2020;106:902-903.
    PubMed    


  231. MARGALIT DN, Karam SD, Chua MLK, Anderson C, et al
    Four Influential Clinical Trials in Human Papilloma Virus-Associated Oropharynx Cancer.
    Int J Radiat Oncol Biol Phys. 2020;106:893-899.
    PubMed    


  232. AMINI A
    Early Stage Oral Tongue Cancer With an Ipsilateral Nodal Recurrence 2 Years Later: What Do You Treat?
    Int J Radiat Oncol Biol Phys. 2020;106:900-901.
    PubMed    


  233. ZHANG J, Ge Y, Sheng Y, Wang C, et al
    Knowledge-Based Tradeoff Hyperplanes for Head and Neck Treatment Planning.
    Int J Radiat Oncol Biol Phys. 2020;106:1095-1103.
    PubMed     Abstract available


  234. LIN CY, Fan KH, Lee LY, Hsueh C, et al
    Precision Adjuvant Therapy Based on Detailed Pathologic Risk Factors for Resected Oral Cavity Squamous Cell Carcinoma: Long-Term Outcome Comparison of CGMH and NCCN Guidelines.
    Int J Radiat Oncol Biol Phys. 2020;106:916-925.
    PubMed     Abstract available


    March 2020
  235. SWISHER-MCCLURE S, Lukens JN, Aggarwal C, Ahn P, et al
    A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
    Int J Radiat Oncol Biol Phys. 2020;106:725-732.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: